Skip to content
In Stock Amaryl
Diabetes

Amaryl

Amaryl is used to improve blood glucose control in adults with type 2 diabetes mellitus. It contains glimepiride, a second-generation sulfonylurea that stimulates the pancreas to release insulin.

Guaranteed quality Original product
Delivery: from 4 days Discreet shipping
24/7 Support Always available
Active ingredient: Glimepiride
Select dosage:
Select pack Package Per unit Price
$ 4.98 $ 149.52
$ 3.89 $ 299.04 $ 233.18 Save 22%
$ 3.52 $ 448.56 $ 316.84 Save 29%
Free Regular Delivery $ 3.34 $ 598.08 $ 400.50 Save 33%
Free Express Delivery $ 3.16 $ 897.12 $ 569.60 Save 37%
Free Express Delivery $ 3.03 $ 1,345.68 $ 817.02 Save 39%
Best value Free Express Delivery $ 2.99 $ 1,794.24 $ 1,076.90 Save 40%
$ 5.58 $ 167.32
$ 4.42 $ 334.64 $ 265.22 Save 21%
Free Regular Delivery $ 4.00 $ 501.96 $ 359.56 Save 28%
Free Regular Delivery $ 3.78 $ 669.28 $ 453.90 Save 32%
Free Express Delivery $ 3.59 $ 1,003.92 $ 646.14 Save 36%
Free Express Delivery $ 3.49 $ 1,505.88 $ 941.62 Save 37%
Best value Free Express Delivery $ 3.41 $ 2,007.84 $ 1,228.20 Save 39%
$ 5.52 $ 165.54
$ 4.36 $ 331.08 $ 261.66 Save 21%
Free Regular Delivery $ 3.98 $ 496.62 $ 357.78 Save 28%
Free Regular Delivery $ 3.80 $ 662.16 $ 455.68 Save 31%
Free Express Delivery $ 3.60 $ 993.24 $ 647.92 Save 35%
Free Express Delivery $ 3.47 $ 1,489.86 $ 938.06 Save 37%
Best value Free Express Delivery $ 3.42 $ 1,986.48 $ 1,231.76 Save 38%
$ 5.52 $ 165.54
$ 3.03 $ 331.08 $ 181.56 Save 45%
$ 2.31 $ 496.62 $ 208.26 Save 58%
$ 1.94 $ 662.16 $ 233.18 Save 65%
$ 1.74 $ 993.24 $ 313.28 Save 68%
Best value Free Express Delivery $ 1.55 $ 1,986.48 $ 557.14 Save 72%

Free delivery on orders from $ 356.00, free express delivery from $ 534.00

Secure payment methods:
VISA AMEX JCB DISCOVER

Amaryl is used to improve blood glucose control in adults with type 2 diabetes mellitus. It contains glimepiride, a second-generation sulfonylurea that stimulates the pancreas to release insulin.

Product information

It is used for adults with type 2 diabetes mellitus when pancreatic beta cells can still produce insulin. Glimepiride is a second-generation sulfonylurea.

Ingredients

Amaryl contains glimepiride, an oral glucose-lowering medicine from the sulfonylurea class.

Therapeutic indications

Amaryl is prescribed to improve glycaemic control in type 2 diabetes mellitus. It may be used alone or alongside other glucose-lowering treatments when diet and physical activity do not provide adequate control.

Directions for use

The tablets are taken alongside an individualised diet and activity plan.

Amaryl is supplied as tablets. The product range includes different glimepiride strengths, including 1 mg and 2 mg presentations. The strength selected for an individual patient depends on blood glucose results, previous treatment, kidney and liver function, age, meal patterns and the risk of hypoglycaemia.

The regimen for the chosen strength should be confirmed with a healthcare professional before starting. Dose increases are gradual rather than automatic, because glimepiride can continue lowering glucose after the dose has been changed.

Tablet Administration

The tablet is taken by mouth and is generally taken with or shortly before the first substantial meal of the day. It should not be taken at a time when a meal will be missed.

A practical detail is easy to overlook: taking the tablet and then delaying the meal creates a mismatch between insulin release and food intake. That is one of the situations in which low blood glucose can develop.

Do not change from a lower to a higher strength based only on a single glucose reading. Treatment decisions use a pattern of readings, glycated haemoglobin, meal timing and tolerability.

When not to use it

The medicine should not be used for type 1 diabetes mellitus or diabetic ketoacidosis.

  • type 1 diabetes mellitus;
  • diabetic ketoacidosis;
  • a known severe allergy to glimepiride, another sulfonylurea or a related sulfonamide medicine;
  • severe kidney or liver impairment unless a specialist has selected a suitable diabetes regimen;
  • recurrent severe hypoglycaemia.

When this is not for you

Amaryl is not suitable for every person with diabetes.

Amaryl is NOT for you if

  • you have type 1 diabetes mellitus;
  • you have diabetic ketoacidosis;
  • you have a known severe allergy to glimepiride, another sulfonylurea or a related sulfonamide medicine;
  • you have severe kidney or liver impairment unless a specialist has selected a suitable diabetes regimen;
  • you cannot maintain a dependable intake of food;
  • you have recurrent severe hypoglycaemia.

Older adults, people who live alone and patients with irregular meals need special attention because early symptoms may be missed. Kidney and liver disease can prolong the glucose-lowering effect, allowing hypoglycaemia to last longer.

Pregnancy requires a different treatment plan because insulin is generally preferred for diabetes control during pregnancy. Breastfeeding also requires a specific review of treatment and infant monitoring.

Unwanted effects

The most clinically significant adverse effect of glimepiride is hypoglycaemia. Commonly reported symptoms include sweating, trembling, hunger, dizziness, headache, blurred vision, irritability, weakness and difficulty concentrating. Nausea, asthenia and other digestive or general symptoms can also occur.

A mild episode may begin with subtle signs. A person may feel unusually tired, become quiet during a conversation, or notice that their hands are trembling. More serious hypoglycaemia can cause confusion, loss of consciousness, seizures or the need for emergency treatment.[1] Act early. Check glucose promptly. Seek help when needed.

Hypoglycaemia

Hypoglycaemia means that blood glucose has fallen below the level needed for normal brain and body function. The risk is higher with:

  • missed or delayed meals;
  • vomiting or reduced food intake;
  • alcohol use;
  • prolonged or unusually intense exercise;
  • kidney or liver impairment;
  • use of insulin or another medicine that lowers glucose;
  • a dose that exceeds the patient’s current needs.

If symptoms occur, a rapid source of glucose is usually used according to the person’s diabetes management plan. Persistent confusion, fainting, seizures or inability to swallow require emergency assistance rather than oral food or drink.

Other Adverse Effects

Dizziness and headache may occur, especially while treatment is being adjusted. Nausea can be more noticeable when meals are irregular. Asthenia describes an unusual lack of strength or energy and may also reflect low glucose rather than a direct medicine effect.

Rare but serious reactions include severe allergy, extensive skin reactions, liver problems and blood-cell abnormalities. Yellowing of the skin, dark urine, facial swelling, breathing difficulty, widespread blistering or unexplained bruising requires urgent assessment.

Keep a quick source of glucose available for recognised low-glucose episodes, such as glucose tablets or another measured rapid carbohydrate source. Chocolate is less reliable for this purpose because its fat content slows glucose absorption.

Mechanism of action

Glimepiride is a second-generation sulfonylurea that acts on pancreatic beta cells to stimulate insulin release. The resulting increase in insulin availability helps lower blood glucose in adults with type 2 diabetes mellitus.

Common mistakes

Several avoidable habits can make Amaryl seem unpredictable:

  • taking the tablet and then skipping the planned meal;
  • doubling the next dose after a missed tablet;
  • changing the strength without reviewing glucose patterns;
  • drinking alcohol without recognising its effect on hypoglycaemia risk;
  • exercising much more than usual without adjusting the diabetes plan;
  • assuming dizziness is harmless without checking for low blood glucose;
  • failing to mention a new corticosteroid, antibiotic, pain reliever or supplement;
  • using the medicine during vomiting or prolonged inability to eat without a sick-day plan.

A missed dose should not normally be replaced by two tablets together. The appropriate action depends on when the omission is noticed, the meal schedule and the prescribed regimen.

Low glucose can be mistaken for anxiety, dehydration or tiredness. A glucose check during symptoms can reveal the cause and provide useful information for treatment adjustment.

Comparison

The closest alternatives are compared by treatment category and mechanism rather than by brand name. The best option depends on kidney function, cardiovascular history, weight goals, meal regularity, hypoglycaemia risk and previous response.

Treatment category Main glucose-lowering approach Main limitation
Glimepiride and other sulfonylureas Stimulate pancreatic insulin release Hypoglycaemia and possible weight gain
Metformin-type therapy Reduces hepatic glucose production and improves insulin sensitivity Gastrointestinal intolerance and restrictions in advanced kidney disease
DPP-4 inhibitor therapy Enhances glucose-dependent insulin release and reduces glucagon signalling Usually more modest glucose lowering; suitability depends on the individual medicine

Glimepiride can be useful when insulin secretion remains available and a strong glucose-lowering effect is needed. Its action is not fully glucose-dependent, so low glucose remains a recognised concern.

Metformin is often used early in type 2 diabetes because it does not usually cause hypoglycaemia when used alone. Gastrointestinal effects can limit its use. DPP-4 inhibitors generally have a lower hypoglycaemia risk when used without insulin or a sulfonylurea, although their glucose-lowering effect may be less pronounced.

What doctors say

In clinical practice, doctors usually focus on three points before prescribing glimepiride: the person’s meal pattern, their hypoglycaemia history and their kidney function. A patient who regularly misses meals may have a poorer fit with a medicine that stimulates insulin release regardless of the exact carbohydrate intake.

A clinician also looks at the pattern behind a high glucose result. One elevated reading does not automatically justify a higher strength. Repeated fasting readings, after-meal levels, glycated haemoglobin and episodes of low glucose provide a more useful picture.

Treatment works best when the tablet is taken at a consistent time in relation to the main meal. A practical issue is that a late breakfast, a skipped meal or an unexpectedly long exercise session can change the effect of the same dose from one day to the next.

The American Diabetes Association and the European Medicines Agency describe sulfonylureas as established glucose-lowering medicines, while treatment selection remains individualised according to risk and clinical circumstances.[2]

What customers often ask

Can Amaryl be used during pregnancy or breastfeeding?

Pregnancy and breastfeeding require an individual treatment decision because glucose targets and medicine exposure must be managed for both parent and child. Insulin is commonly preferred during pregnancy when medication treatment is required, while sulfonylurea use depends on the clinical situation. The TGA and EMA product information for glimepiride advises careful consideration of pregnancy and lactation, with treatment changes made before exposure whenever possible. A 2026 treatment review should include glucose control, pregnancy stage, feeding plans and the risk of hypoglycaemia for the parent.[3]

Is Amaryl suitable for people under 18?

Amaryl is intended for adult type 2 diabetes management, and routine use in children and adolescents is not established in the same way as adult treatment. Type 2 diabetes in younger people often requires a specialist-led plan involving lifestyle measures and medicines selected for the patient’s age and condition. The WHO diabetes guidance and TGA regulatory information support age-specific treatment decisions rather than automatic transfer of an adult regimen. A 2026 paediatric review should therefore be arranged through an appropriate diabetes service.

How is Amaryl used in older adults?

Older adults may respond more strongly to glimepiride because kidney function, appetite and medication clearance can change with age. Hypoglycaemia may present as confusion, unsteadiness, unusual sleepiness or a fall instead of obvious sweating or tremor. The American Diabetes Association Standards of Care 2025 recommends individualised targets and careful assessment of hypoglycaemia risk in older people. Lower starting exposure, slower adjustments and review of meal regularity are common clinical considerations.[4]

Can the Amaryl tablet be split, crushed or chewed?

The tablet should be swallowed in the manner specified for the particular presentation, and splitting, crushing or chewing should not be assumed to be suitable. A tablet may have a score line, but that does not automatically confirm dose uniformity after division. Crushing can also make administration more difficult for a person who is at risk of taking the dose without eating. The EMA product information (2024) and the Australian prescribing information should guide any change to the way the tablet is taken, with the regimen confirmed before starting.

How long does a course of Amaryl last, and is long-term use acceptable?

Amaryl is generally used as part of ongoing type 2 diabetes management rather than as a fixed short course. Long-term treatment can be appropriate when glucose control is improved and hypoglycaemia, kidney function, liver function and weight remain acceptable. The need for continued treatment is reviewed through glycated haemoglobin, home glucose results, adverse effects and changes in health. Guidance from the WHO and the ADA in 2025 supports regular reassessment because diabetes treatment may need to change over time.

Should Amaryl be taken with food or on an empty stomach?

Amaryl is generally taken shortly before or with the first substantial meal of the day, not on an empty stomach when a meal is being skipped. The meal provides carbohydrate that matches the insulin release stimulated by glimepiride. Taking it and then delaying food can increase the chance of hypoglycaemia. The TGA (2024) and EMA (2024) information for glimepiride supports consistent meal-related administration, while the exact schedule should follow the confirmed regimen.

Can Amaryl be combined with corticosteroids or supplements?

Corticosteroids can raise blood glucose and may reduce the glucose-lowering effect of glimepiride, so closer monitoring may be needed when a steroid is started, stopped or changed. Some supplements may also affect glucose levels or contain ingredients that interact with diabetes treatment. The FDA drug information for glimepiride and clinical pharmacology references support reviewing all medicines, vitamins and herbal products together. During 2026, any new supplement should be disclosed before the regimen is adjusted, especially if it is marketed for blood glucose, weight or exercise performance.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Actos

Active ingredient: Pioglitazone
15mg 30mg 45mg
From $ 108.58
pills
4 (3)

Amaryl Current

Active ingredient: Glimepiride
2mg 3mg 4mg 1mg
From $ 149.52
pills
4.1 (5)

Empagliflozin

Active ingredient: Empagliflozin
10mg 25mg
From $ 332.86
pills
4.1 (5)

Forxiga

Active ingredient: Dapagliflozin
10mg 5mg
From $ 229.62
pills
4.3 (4)

Glucophage

Active ingredient: Metformin
1000mg 500mg 850mg 250mg
From $ 181.56
pills
3.9 (5)

Karela

Active ingredient: Karela
250mg
From $ 218.94
pills
3.5 (5)

How the medicines for Diabetes compare

Sources

  1. U.S. Food and Drug Administration (2023). Amaryl (glimepiride) tablets prescribing information.
  2. American Diabetes Association (2025). Standards of Care in Diabetes—2025.
  3. Therapeutic Goods Administration (2024). Australian Product Information for glimepiride.
  4. World Health Organization (2023). WHO guideline for the pharmacological treatment of type 2 diabetes in adults.

How Buyers Rate Amaryl

Based on 5 reviews

Peter, 57 Verified
Rating: 4 out of 5

I used the starting strength after my diabetes review. My morning readings improved, but I had one sweaty, shaky episode after missing lunch. Once I stopped skipping meals, the problem did not repeat.

For several weeks 5 Oct 2026
Lee, 59 Verified
Rating: 4 out of 5

My readings were steadier and I did not notice stomach problems. The difficult part was remembering that a tablet taken before a delayed meal could leave me feeling weak.

For about a month 11 Oct 2026
Christopher, 56 Verified
Rating: 5 out of 5

The treatment helped my glucose results. I still needed regular checks because increasing the dose was not as simple as taking more after one high reading.

For three months 18 Oct 2026
Colin D., 29 Verified
Rating: 3.5 out of 5

I had headaches and felt light-headed. The symptoms improved after my clinician reviewed the timing with meals, but I would not take it before exercise without planning food and monitoring.

For the first few days 25 Oct 2026
Mark M., 62 Verified
Rating: 4 out of 5

My readings improved, although I gained some weight and had to pay closer attention to portions. The benefit was real, but it required a regular routine.

For several weeks 3 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 491 reviews Install